CDK13 and nonpapillary renal cell carcinoma: Here we identify CDK13 as a master orchestrator of lipid dysregulation in ccRCC, demonstrating that it drives de novo lipogenesis through a phosphorylation-dependent RNA N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) modification axis.